The effect of PD-L1 testing on the cost-effectiveness and economic impact of immune checkpoint inhibitors for the second-line treatment of NSCLC

Overview of attention for article published in Annals of Oncology, September 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news: 1 news outlet
twitter: 10 X users
patent: 5 patents

facebook: 1 Facebook page
reddit: 1 Redditor

Readers on

mendeley: 144 Mendeley

So far, Altmetric has seen 10 X posts from 10 X users, with an upper bound of 23,709 followers.

effect of PD-L1 testing on the cost-effectiveness and economic impact of immune checkpoint inhibitors for the second-line treatment of NSCLC | Annals of Oncology | Oxford Academic https://t.co/cE4tVmZbzS

RT @JTrentMDPhD: Spectacular #international #Clinicaltrial @GlopesMd Impact of PD-L1 testing on cost effectiveness https://t.co/46nXi0CCSC…

Spectacular #international #Clinicaltrial @GlopesMd Impact of PD-L1 testing on cost effectiveness https://t.co/46nXi0CCSC @SylvesterCancer

RT @bmassutis: effect of PD-L1 test on cost-effectiveness and economic impact immune checkpoint inh 2nd line NSCLC Ann Oncol https://t.co…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 6 additional X posts.